Where does Albireo AB rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Albireo AB ranks #6,616 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Albireo AB hold?

Albireo AB holds 50 US utility patents granted between 2015 and 2025, spanning 8 technology areas.

What is Albireo AB's Innovation Score?

Albireo AB has an Innovation Score of 40.5 out of 100 (top 35% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Albireo AB focus on?

Albireo AB's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 38 patents, ranking #491 of 6,058 assignees active in that subclass. Grants appear in 8 CPC subclasses total.

Is Albireo AB's patent grant rate increasing or decreasing?

Albireo AB's recent grant velocity is +218% compared to the prior five-year period (grant years, not application filing dates). This indicates accelerating grant output.

What does claim depth mean for Albireo AB's patents?

Albireo AB's patents average 17.1 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Albireo AB patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Albireo AB

USPTO PatentsView assignee record - 50 granted patents across 8 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Albireo ranks #6,616 of 49,997 tracked US assignees by granted-patent volume, with 50 patents across 8 technology areas.

#6,616
of 49,997 US assignees by volume: Top 35%
by Innovation Score (40.5/100): 17.1
avg claims per patent: +218%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R6616 · Foreign Corporation #6,616 · 50 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

GRANTS-SMALL 50 grants
UPPER-Q #6,616/49,997
PHOTO-FINISH AIC Innovations Group
CPC-NARROW A61P · 8 areas
INNOV-PAR 40.5/100
CLAIMS-RICH 17.1 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-SURGE +218% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: AIC Innovations Group, Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Albireo’s 40.5 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 13.6 pts (34%) Velocity 6.7 pts (17%) Breadth 10.0 pts (25%) Claim depth 10.2 pts (25%)

Qualcomm Incorporated · highest

85
Albireo AB · this assignee

40
Aqseptence Group · near

40
Fastly · near

40
Geosat Aerospace &… · near

40
Reflect Scientific · near

40
3D Lighting… · lowest

7

What this shows Albireo's Innovation Score is 40.5/100 (top 35% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Albireo?

Each dot is one of Albireo’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Albireo’s own 17.1 claims/patent is ABOVE the 13.6 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Albireo vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Albireo's grants concentrate

Albireo AB is a focused PatentsView assignee: 8 CPC subclasses with 76% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2023 (9 grants) versus a trough of 1 in 2015. By volume, Albireo sits between Xenon Pharmaceuticals Inc. and Avintiv Specialty Materials Inc..

Albireo's three-year grant acceleration

From 2019–2021 to 2022–2024, Albireo AB moved from 20 to 20 grants (1.00x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Xenon Pharmaceuti…

51
Yoshino Gypsum

51
AIC Innovations G…

50
Aker Solutions AS

50
Alfred KÄRcher SE…

50
Amazing Microelec…

50
Asco Power

50
Avintiv Specialty…

50
Albireo AB ◀

50

What this shows Albireo holds 50 patents at rank #6,613, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Albireo

By rank, the assignees closest to #6,613 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Albireo's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Albireo, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Albireo ranks #491 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (40 here).

Fastly, Inc. 40 Aqseptence Group, Inc. 40 Geosat Aerospace & Technology Inc. 40 Reflect Scientific Inc. 40

Similar claim depth

Nearest assignees by average claims per patent (17.1 here).

Innoscience (SUZHOU) Technology Co., Ltd. 17.1 avg GRÜNENTHAL GMBH 17.1 avg Angel Co., Ltd. 17.1 avg STC.UNM 17.1 avg

Albireo's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 35% higher than 65% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Albireo AB patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	2.0%
2017	2	4.0%
2018	3	6.0%
2019	5	10.0%
2020	7	14.0%
2021	8	16.0%
2022	6	12.0%
2023	9	18.0%
2024	5	10.0%
2025partial year	4	8.0%

Which technologies does Albireo AB patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 38

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 33

C07D - Heterocyclic Compounds 26

C07K - Peptides 11

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 5

Y02A - Technologies FOR Adaptation TO Climate Change 4

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 1

C07C - Acyclic OR Carbocyclic Compounds 1

Top 8 of 8 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Albireo AB's patent record in context - here's where to go next.

Albireo AB's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 76% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #6,616 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Albireo AB against Xenon Pharmaceuticals Inc., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 40.5/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.